DME (psychedelic)

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
DME (psychedelic)
DME (psychedelic).png
DME-3d-sticks.png
Names
IUPAC name
2-Amino-1-(3,4-dimethoxy-phenyl)-ethanol
Other names
3,4-Dimethoxy-beta-hydroxyphenethylamine
3,4-Dimethoxy-1-ethyl-(beta-hydroxy)amine
Identifiers
3D model (JSmol)
ChemSpider
Properties
C10H15NO3
Molar mass 197.23 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☑Y verify (what is ☑Y☒N ?)
Infobox references

DME, or 3,4-dimethoxy-beta-hydroxyphenethylamine, is a lesser-known psychedelic drug. It is the beta-hydroxy analog of DMA. DME was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 115 mg, and the duration unknown. DME produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of DME.

Legality[edit]

United Kingdom[edit]

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[1]

See also[edit]

External links[edit]

  1. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.